Bipin C Shah 's Insider Trades & SAST Disclosures
Bipin C Shah 's most recent trade in Senores Pharmaceuticals Ltd. was a Acquisition of 550 Equity Shares done at an average price of Rs. 564.4 . Disclosure was reported to the exchange on March 13, 2025 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
Bipin C Shah 's has made SAST transactions in Shreeji Translogistics Ltd. recently where a Acquisition of 372,750 shares done . Disclosure was reported to the exchange on Oct. 5, 2021.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Senores Pharmaceuticals Ltd. | Chetan Bipinchandra Shah | Director | Acquisition | 13 Mar 2025 | 550 | 3,550 (0.01%) | 0.00% | 564.4 | 310,415 | 12 Mar 2025 12 Mar 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals Ltd. | Chetan Bipinchandra Shah | Director | Acquisition | 27 Feb 2025 | 1,000 | 2,000 (0%) | 0.00% | 552.4 | 552,360 | 24 Feb 2025 24 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals Ltd. | Chetan Bipinchandra Shah | Director | Acquisition | 27 Feb 2025 | 1,000 | 3,000 (0%) | 0.00% | 561.8 | 561,830 | 25 Feb 2025 25 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals Ltd. | Chetan Bipinchandra Shah | Director | Acquisition | 21 Feb 2025 | 298 | 522 (0%) | 0.00% | 521.9 | 155,541 | 19 Feb 2025 19 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals Ltd. | Chetan Bipinchandra Shah | Director | Acquisition | 21 Feb 2025 | 142 | 984 (0%) | 0.00% | 522.4 | 74,181 | 19 Feb 2025 19 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals Ltd. | Chetan Bipinchandra Shah | Director | Acquisition | 21 Feb 2025 | 95 | 660 (0%) | 0.00% | 522.1 | 49,604 | 19 Feb 2025 19 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals Ltd. | Chetan Bipinchandra Shah | Director | Acquisition | 21 Feb 2025 | 76 | 773 (0%) | 0.00% | 522.3 | 39,691 | 19 Feb 2025 19 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals Ltd. | Chetan Bipinchandra Shah | Director | Acquisition | 21 Feb 2025 | 46 | 819 (0%) | 0.00% | 522.3 | 24,026 | 19 Feb 2025 19 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals Ltd. | Chetan Bipinchandra Shah | Director | Acquisition | 21 Feb 2025 | 37 | 697 (0%) | 0.00% | 522.2 | 19,321 | 19 Feb 2025 19 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals Ltd. | Chetan Bipinchandra Shah | Director | Acquisition | 21 Feb 2025 | 34 | 184 (0%) | 0.00% | 521.6 | 17,736 | 19 Feb 2025 19 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals Ltd. | Chetan Bipinchandra Shah | Director | Acquisition | 21 Feb 2025 | 29 | 214 (0%) | 0.00% | 521.8 | 15,132 | 19 Feb 2025 19 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals Ltd. | Chetan Bipinchandra Shah | Director | Acquisition | 21 Feb 2025 | 23 | 842 (0%) | 0.00% | 522.3 | 12,014 | 19 Feb 2025 19 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals Ltd. | Chetan Bipinchandra Shah | Director | Acquisition | 21 Feb 2025 | 23 | 565 (0%) | 0.00% | 522.1 | 12,008 | 19 Feb 2025 19 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals Ltd. | Chetan Bipinchandra Shah | Director | Acquisition | 21 Feb 2025 | 20 | 542 (0%) | 0.00% | 522.1 | 10,441 | 19 Feb 2025 19 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals Ltd. | Chetan Bipinchandra Shah | Director | Acquisition | 21 Feb 2025 | 16 | 1,000 (0%) | 0.00% | 522.4 | 8,359 | 19 Feb 2025 19 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals Ltd. | Chetan Bipinchandra Shah | Director | Acquisition | 21 Feb 2025 | 10 | 224 (0%) | 0.00% | 521.9 | 5,219 | 19 Feb 2025 19 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals Ltd. | Chetan Bipinchandra Shah | Director | Acquisition | 21 Feb 2025 | 1 | 185 (0%) | 0.00% | 522 | 522 | 19 Feb 2025 19 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Shreeji Translogistics | Bipin C Shah & PACs | Promoter | Acquisition | 05 Oct 2021 | 372,750 | 736,950 (7.03%) | 3.56% | - | 01 Oct 2021 01 Oct 2021 |
SAST (29(1)) | - | Transmission |
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.